Second Line Treatment of EGFR Positive Lung Adenocarcinoma - Our Experience

被引:0
作者
Seiwerth, Fran [1 ]
Bitar, Lela [1 ]
Markelic, Ivona [1 ]
Dzubur, Fedza [1 ]
Brcic, Luka [2 ]
Seiwerth, Sven [3 ]
Misic, Marija [3 ]
Roglic, Mihovil [1 ]
Plestina, Sanja [1 ]
Cucevic, Branka [1 ]
Kukulj, Suzana [1 ]
Smojver-Jezek, Silvana [1 ]
Samarzija, Miroslav [1 ]
Jakopovic, Marko [1 ]
机构
[1] Univ Hosp Ctr Zagreb, Dept Resp Dis Jordanovac, Zagreb, Croatia
[2] Med Univ Graz, Inst Pathol, Graz, Austria
[3] Univ Zagreb, Sch Med, Dept Pathol, Zagreb, Croatia
关键词
EGFR;
D O I
10.1016/j.jtho.2016.11.1782
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.02b-114
引用
收藏
页码:S1262 / S1262
页数:1
相关论文
共 50 条
  • [21] Profiling of driver mutations in lung adenocarcinoma patients identifies rare compound EGFR mutations sensitive to second-generation EGFR-TKIs
    Jun Li
    Cuiyun Zhang
    Yuping Guan
    Siyu Wang
    Jiawen Zheng
    Junnan Feng
    Sile Han
    Ruijuan Ma
    Pengfei Ren
    Shasha Li
    Harry J. M. Groen
    Klaas Kok
    Anke van den Berg
    Bing Wei
    Jie Ma
    Hongle Li
    Yongjun Guo
    Holistic Integrative Oncology, 3 (1):
  • [22] Clinicopathological characteristics of lung adenocarcinoma with compound EGFR mutations
    Hayashi, Takuo
    Kohsaka, Shinji
    Takamochi, Kazuya
    Hara, Kieko
    Kishikawa, Satsuki
    Sano, Kei
    Takahashi, Fumiyuki
    Suehara, Yoshiyuki
    Saito, Tsuyoshi
    Takahashi, Kazuhisa
    Suzuki, Kenji
    Yao, Takashi
    HUMAN PATHOLOGY, 2020, 103 : 42 - 51
  • [23] EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition
    Rotella, Virginia
    Fornaro, Lorenzo
    Vasile, Enrico
    Tibaldi, Carmelo
    Boldrini, Laura
    Chella, Antonio
    D'Incecco, Armida
    Cirigliano, Giovanna
    Chioni, Aldo
    Lupi, Cristiana
    Sensi, Elisa
    Ginocchi, Laura
    Giovannelli, Simona
    Pennucci, Maria Cristina
    Fontanini, Gabriella
    Baldini, Editta
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2014, 33
  • [24] EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition
    Virginia Rotella
    Lorenzo Fornaro
    Enrico Vasile
    Carmelo Tibaldi
    Laura Boldrini
    Antonio Chella
    Armida D'Incecco
    Giovanna Cirigliano
    Aldo Chioni
    Cristiana Lupi
    Elisa Sensi
    Laura Ginocchi
    Simona Giovannelli
    Maria Cristina Pennucci
    Gabriella Fontanini
    Editta Baldini
    Journal of Experimental & Clinical Cancer Research, 33
  • [25] Effective treatment with icotinib in lung adenocarcinoma with EGFR and ALK co-alterations and brain metastasis
    Ye, Chenyang
    Wang, Ji
    Zheng, Shu
    Chai, Ying
    ONCOTARGETS AND THERAPY, 2016, 9 : 6605 - 6608
  • [26] Real-World Effectiveness of EGFR TKI First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer in US
    Gautam, S.
    Herms, L.
    Bartolome, L.
    Pastel, M.
    Wilner, K.
    Fisher, M.
    Ivanova, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S618 - S619
  • [27] Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung Adenocarcinoma
    Taus, Alvaro
    Camacho, Laura
    Rocha, Pedro
    Hardy-Werbin, Max
    Pijuan, Lara
    Piquer, Gabriel
    Lopez, Eva
    Dalmases, Alba
    Longaron, Raquel
    Clave, Sergi
    Salido, Marta
    Albanell, Joan
    Bellosillo, Beatriz
    Arriola, Edurne
    CLINICAL LUNG CANCER, 2018, 19 (05) : 387 - +
  • [28] The Efficacy of First-Generation EGFR-TKI Combined With Brain Radiotherapy as the First-Line Treatment for Lung Adenocarcinoma Patients With Brain Metastases and EGFR Sensitive Mutations: A Retrospective study
    Liu, Yuting
    Wang, Juanjuan
    Wu, Jingjing
    Yang, Qifan
    Zeng, Yulan
    Wu, Di
    Tian, Chen
    Hu, Yue
    Gu, Feifei
    Li, Chang
    Zhang, Kai
    Liu, Li
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [29] Positive response to Icotinib in metastatic lung adenocarcinoma with acquiring EGFR Leu792H mutation after AZD9291 treatment: a case report
    Wang, Junhui
    Chen, Jianxin
    BMC CANCER, 2019, 19 (1)
  • [30] Long-Term Outcomes in Patients with EGFR Positive Lung Adenocarcinoma and Subgroup Analysis Based on Presence of Liver Metastases
    Krstic, Vesna Ceriman
    Soldatovic, Ivan
    Samardzic, Natalija
    Gajic, Milija
    Kontic, Milica
    Reljic, Aleksandar
    Savic, Milan
    Milenkovic, Marina Roksandic
    Jovanovic, Dragana
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (12) : 13431 - 13442